These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3878249)

  • 21. 1,25(OH)2D levels in dihydrotachysterol-treated patients: influence on 1,25(OH)2D assays.
    Taylor A; Norman ME
    J Bone Miner Res; 1987 Dec; 2(6):567-70. PubMed ID: 2844067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of bone disease with dihydrotachysterol in patients undergoing long-term hemodialysis.
    Cordy PE
    Can Med Assoc J; 1977 Oct; 117(7):766-8. PubMed ID: 907948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proceedings: Effect of dihydrotachysterol on azotemic renal osteodystrophy.
    Kawaguchi Y; Sakai S; Ogura Y; Kimura Y; Yamamoto M
    Calcif Tissue Res; 1974; 15(2):160. PubMed ID: 4844400
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of 25-hydroxycholecalciferol on bone lesions of children with terminal renal failure.
    Witmer G; Margolis A; Fontaine O; Fritsch J; Lenoir G; Broyer M; Balsan S
    Kidney Int; 1976 Nov; 10(5):395-408. PubMed ID: 794558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of 1,25-dihydroxyvitamin-D3 on renal function, mineral balance, and growth in children with severe chronic renal failure.
    Chan JC; Kodroff MB; Landwehr DM
    Pediatrics; 1981 Oct; 68(4):559-71. PubMed ID: 6895662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term effects of small doses of 1,25-dihydroxycholecalciferol in renal osteodystrophy.
    Ahmed KY; Varghese Z; Wills MR; Meinhard EA; Moorhead JF
    Lancet; 1978 Mar; 1(8065):629-32. PubMed ID: 76168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Renal osteopathy and bone mineralisation in patients treated with dihydrotachysterol during long term dialysis (author's transl)].
    Pogglitsch H; Schmidberger H; Gell G
    MMW Munch Med Wochenschr; 1976 Jan; 118(5):131-6. PubMed ID: 814443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evolving aspects of uremic osteodystrophy in the dialized patient].
    Zucchelli P; Fusaroli M; Fabbri L; Catizone L; Pavlica P; Viglietta G; Casanova S
    J Urol Nephrol (Paris); 1976; 82(4-5):325-8. PubMed ID: 940176
    [No Abstract]   [Full Text] [Related]  

  • 29. Renal osteodystrophy in children with end-stage kidney failure.
    Chan JC
    Va Med; 1979 May; 106(5):384-90. PubMed ID: 463255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of renal osteodystrophy].
    Duursma SA; Dorhout Mees EJ
    Ned Tijdschr Geneeskd; 1978 Mar; 122(11):373-8. PubMed ID: 634388
    [No Abstract]   [Full Text] [Related]  

  • 31. Renal hypophosphatemic rickets: growth acceleration after long-term treatment with 1,25-dihydroxyvitamin-D3.
    Chan JC; Lovinger RD; Mamunes P
    Pediatrics; 1980 Sep; 66(3):445-54. PubMed ID: 6893489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal osteodystrophy in children with chronic renal failure: an unexpectedly common and incapactating complication.
    Hsu AC; Kooh SW; Fraser D; Cumming WA; Fornasier VL
    Pediatrics; 1982 Nov; 70(5):742-50. PubMed ID: 6982452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bone metabolism markers and bone histomorphometry in children with chronic renal failure in predialysis period during growth hormone treatment].
    Pańczyk-Tomaszewska M; Ziółkowska H; Debiński A; Sawicki A; Zurowska A; Pietrzyk JA; Roszkowska-Blaim M
    Pol Merkur Lekarski; 2000 Apr; 8(46):264-5. PubMed ID: 10897642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Questions on the use of vitamin D3.
    Balsan S; Steendijk R
    Pediatrics; 1980 Sep; 66(3):483-4. PubMed ID: 7422447
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparisons between oral and intraperitoneal 1,25-dihydroxyvitamin D3 therapy in children treated with peritoneal dialysis.
    Jones CL; Vieth R; Spino M; Ledermann S; Kooh SW; Balfe J; Balfe JW
    Clin Nephrol; 1994 Jul; 42(1):44-9. PubMed ID: 7923966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Aluminum in renal osteodystrophy].
    Zhu P; Wang GY; Yu YF; Zhu P
    Zhonghua Nei Ke Za Zhi; 1993 Mar; 32(3):176-8. PubMed ID: 8222983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapy of renal osteodystrophy with dihydrotachysterol in non-dialyzed patients.
    Teredesai P; Winaver J; Martin LG; Cranley R; Conner TB; Hartsock RJ; Puschett JB
    Clin Nephrol; 1980 Jan; 13(1):31-9. PubMed ID: 7363513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interrelationship of serum 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D in juvenile renal osteodystrophy after therapy with 25-hydroxyvitamin D3.
    Taylor A; Norman ME
    Metab Bone Dis Relat Res; 1982; 4(4):255-61. PubMed ID: 6897822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of parathyroidectomy on circulating levels of 1 alpha,25-dihydroxyvitamin D and bone Gla protein in dialyzed patients.
    Fanti P; Smith AJ; Price PA; Reitz RE; Malluche HH
    J Clin Endocrinol Metab; 1986 May; 62(5):869-73. PubMed ID: 3485651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.